{"id":120776,"date":"2019-11-05T07:21:07","date_gmt":"2020-04-21T00:45:47","guid":{"rendered":"http:\/\/www.05921.net\/index.php\/120776\/"},"modified":"2020-04-21T08:45:49","modified_gmt":"2020-04-21T00:45:49","slug":"508266a0f4","status":"publish","type":"post","link":"https:\/\/www.05921.net\/index.php\/120776\/","title":{"rendered":"\u8054\u4e9a\u836f\u4e1a\uff1a\u76d0\u9178\u5965\u6614\u5e03\u5b81\u7247ANDA\u83b7\u6279\uff08\u5df2\u83b7\u6279\u6570\u5341\u4e2a\uff09"},"content":{"rendered":"
\n

\"\u8054\u4e9a\u836f\u4e1a\uff1a\u76d0\u9178\u5965\u6614\u5e03\u5b81\u7247ANDA\u83b7\u6279\uff08\u5df2\u83b7\u6279\u6570\u5341\u4e2a\uff09\"<\/p>\n

Product Details for ANDA 210611<\/span>
<\/h3>\n

OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE) 5MG 
Marketing Status: Prescription<\/span><\/p>\n


<\/span><\/p>\n

Active Ingredient:<\/strong> OXYBUTYNIN CHLORIDE <\/span>
Proprietary Name:<\/strong> OXYBUTYNIN CHLORIDE <\/span>
Dosage Form; Route of Administration:<\/strong> TABLET; ORAL <\/span>
Strength:<\/strong> 5MG <\/span>
Reference Listed Drug:<\/strong> No <\/span>
Reference Standard:<\/strong> No <\/span>
TE Code:<\/strong> AB <\/span>
Application Number:<\/strong> A210611 <\/span>
Product Number:<\/strong> 001 <\/span>
Approval Date:<\/strong> Oct 30, 2019 <\/span>
Applicant Holder Full Name:<\/strong> NOVAST LABORATORIES LTD <\/span>
Marketing Status:<\/strong>  Prescription <\/span>
Patent and Exclusivity Information<\/span><\/p>\n


<\/p>\n

\u76ee\u524d\u5357\u901a\u8054\u4e9a\u836f\u4e1a\u5728\u7f8e\u56fd\u5e02\u573a\u83b7\u6279\u4e0a\u5e02\u7684\u54c1\u79cd\u591a\u8fbe\u6570\u5341\u4e2a\uff0c\u5176\u4e2d\u591a\u4e2a\u4e3a\u7f13\u63a7\u91ca\u4ea7\u54c1\u3002<\/span><\/strong><\/span><\/p>\n


<\/p>\n

\"\u8054\u4e9a\u836f\u4e1a\uff1a\u76d0\u9178\u5965\u6614\u5e03\u5b81\u7247ANDA\u83b7\u6279\uff08\u5df2\u83b7\u6279\u6570\u5341\u4e2a\uff09\"<\/p>\n


<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"

Product Details for ANDA 210611 OXYBUTYNIN CHLORIDE (OX […]<\/p>\n","protected":false},"author":1,"featured_media":120777,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[2],"tags":[],"_links":{"self":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts\/120776"}],"collection":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/comments?post=120776"}],"version-history":[{"count":1,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts\/120776\/revisions"}],"predecessor-version":[{"id":120780,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts\/120776\/revisions\/120780"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/media\/120777"}],"wp:attachment":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/media?parent=120776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/categories?post=120776"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/tags?post=120776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}